TapImmune Inc. (OTCMKTS:TPIV) Slips And Slides
TapImmune Inc. (OTCMKTS:TPIV)’s chart performance is like a rollercoaster. The company stock constantly goes up and then comes flying down, although the daily percentile movements remain relatively small.
The company has a market valuation of around $37 million, which is rather decent for an OTC marketplace entity with TPIV’s balance sheet. Here is a quick example of the numbers contained in the company’s report for the first quarter of this year.
- cash: $6.57 million
- current assets: $6.64 million
- current liabilities: $28 million
- revenues: ZERO
- loss from operations: $6.15 million
It appears that the company has decent cash reserves and current assets. The liabilities, however, seem quite significant as well and it doesn’t really look like TPIV will begin generating revenues any time soon, while the net losses from operations are also quite big.
The company has been more busy issuing optimistic press releases lately, but that doesn’t seem to be helping the price of the stock that much. In fact, TPIV, who is used to making small percentile movements, dropped 7.44% in yesterday’s trading, closing at $0.54, while a total of 540 thousand traded shares generated $292 thousand in daily dollar volume.
The ticker seems to be doing a bit better today, but that doesn’t mean that you should skip doing your due diligence and weighing out the risks before putting any money on the line.
